Coronavirus disease 2019 (COVID-19): An evidence map of medical literature

BMC Medical Research Methodology

Volumn 20, Issue 1, 2020, Pages

  Liu, Nan ^a,b   Chee, Marcel Lucas ^c   Niu, Chenglin ^a   Pek, Pin Pin ^a,d   Siddiqui, Fahad Javaid ^a   Ansah, John Pastor ^a   Matchar, David Bruce ^a,e   Lam, Sean Shao Wei ^a,b   Abdullah, Hairil Rizal ^a,d   Chan, Angelique ^a   Malhotra, Rahul ^a   Graves, Nicholas ^a   Koh, Mariko Siyue ^a,d   Yoon, Sungwon ^a   Ho, Andrew Fu Wah ^a,d   Ting, Daniel Shu Wei ^a,f   Low, Jenny Guek Hong ^a,d   Ong, Marcus Eng Hock ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Singapore Health Services   (Singapore)

^c MONASH UNIVERSITY   (Australia)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

Coronavirus; COVID 19; Evidence gap map; Review; SARS CoV 2

Indexed keywords

BIBLIOMETRICS; CORONAVIRUS INFECTION; HUMAN; LITERATURE; MEDLINE; PANDEMIC; PUBLICATION; VIRUS PNEUMONIA;

BIBLIOMETRICS; CORONAVIRUS INFECTIONS; HUMANS; LITERATURE; PANDEMICS; PERIODICALS AS TOPIC; PNEUMONIA, VIRAL; PUBMED;

EID: 85087471374     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/s12874-020-01059-y     Document Type: Article

References (60)

1. WHO Timeline - COVID-19. https://www.who.int/news-room/detail/27-04-2020-who-timeline - -covid-19. Accessed 6 May 2020.
2. Publications & Data: European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/publications-data. Accessed 14 June 2020.
3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74.
4. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953-66.
5. Zhong NS, Zheng BJ, Li YM, Poon XZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet. 2003;362(9393):1353-8.
6. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814-20.
7. Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. J Clin Med. 2020;9(4).
8. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S: A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020;57:279-83.
9. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF et al: Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020:101623-101623.
10. Marx W, Schier H, Wanitschek M. Citation analysis using online databases: feasibilities and shortcomings. Scientometrics. 2001;52(1):59-82.
11. Lou J, Tian SJ, Niu SM, Kang XQ, Lian HX, Zhang LX, Zhang JJ. Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci. 2020;24(6):3411-21.
12. Chahrour M, Assi S, Bejjani M, Nasrallah AA, Salhab H, Fares M, Khachfe HH. A Bibliometric analysis of COVID-19 research activity: a call for increased output. Cureus. 2020;12(3):e7357.
13. Boutron I, Chaimani A, Devane D, and JJM, Tovey D, Hróbjartsson A, Ravaud P: Interventions for preventing and treating COVID-19: protocol for a living mapping of research and a living systematic review. Zenodo 2020;3903347.
14. Snilstveit B, Vojtkova M, Bhavsar A, Stevenson J, Gaarder M. Evidence & gap maps: a tool for promoting evidence informed policy and strategic research agendas. J Clin Epidemiol. 2016;79:120-9.
15. Saran A, White H. Evidence and gap maps: a comparison of different approaches. Campbell Syst Rev. 2018;14(1):1-38.
16. Katz DL, Williams AL, Girard C, Goodman J, Comerford B, Behrman A, Bracken MB. The evidence base for complementary and alternative medicine: methods of evidence mapping with application to CAM. Altern Ther Health Med. 2003;9(4):22-30.
17. Hirsch JE. An index to quantify an individual's scientific research output. Proc Natl Acad Sci U S A. 2005;102(46):16569-72.
18. Roser M, Ritchie H, Ortiz-Ospina E, Hasell J: "Coronavirus disease (COVID-19)". In. OurWorldInData.org; 2020.
19. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X et al: Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020;26:672-5.
20. Chiu W-T, Huang J-S, Ho Y-S. Bibliometric analysis of severe acute respiratory syndrome-related research in the beginning stage. Scientometrics. 2004;61(1):69-77.
21. Zyoud SH. Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis. BMC Infect Dis. 2016;16(1).
22. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
23. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M et al: A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020;382(19):1787-99.
24. Ting DSW, Carin L, Dzau V, Wong TY. Digital technology and COVID-19. Nat Med. 2020;26(4):459-61.
25. Wong ZSY, Zhou J, Zhang Q. Artificial intelligence for infectious disease big data analytics. Infect Dis Health. 2019;24(1):44-8.
26. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436.
27. Li L, Qin L, Xu Z, Yin Y, Wang X, Kong B, Bai J, Lu Y, Fang Z, Song Q et al: Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT. Radiology 2020;200905.
28. Siettos CI, Russo L. Mathematical modeling of infectious disease dynamics. Virulence. 2013;4(4):295-306.
29. Wang H, Wang Z, Dong Y, Chang R, Xu C, Yu X, Zhang S, Tsamlag L, Shang M, Huang J, et al. Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China. Cell Discov. 2020;6:10.
30. Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, Eggo RM: Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis 2020;20(5):553-8.
31. Fang Y, Nie Y, Penny M. Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: a data-driven analysis. J Med Virol. 2020;92(6):645-59.
32. Jewell NP, Lewnard JA, Jewell BL: Predictive mathematical models of the COVID-19 pandemic: underlying principles and value of projections. JAMA 2020;323(19):1893-4.
33. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science (New York, NY). 2020:eabb5793.
34. Shaban-Nejad A, Michalowski M, Buckeridge DL. Health intelligence: how artificial intelligence transforms population and personalized health. NPJ Digit Med. 2018;1:53.
35. Wilder B, Suen S-C, Tambe M: Preventing infectious disease in dynamic populations under uncertainty. In: Thirty-Second AAAI Conference on Artificial Intelligence: 2018; 2018.
36. Bent O, Remy SL, Roberts S, Walcott-Bryant A: Novel exploration techniques (NETs) for malaria policy interventions. In: Thirtieth AAAI Conference on Innovative Applications of Artificial Intelligence: 2018; 2018.
37. Manogaran G, Mahroum N, Adawi M, Sharif K, Waknin R, Mahagna H, Bisharat B, Mahamid M, Abu-Much A, Amital H, et al. Public reaction to Chikungunya outbreaks in Italy - Insights from an extensive novel data streams-based structural equation modeling analysis. PLoS One. 2018;13(5).
38. Olson DR, Bragazzi NL, Alicino C, Trucchi C, Paganino C, Barberis I, Martini M, Sticchi L, Trinka E, Brigo F, et al. Global reaction to the recent outbreaks of Zika virus: Insights from a Big Data analysis. PLoS One. 2017;12(9).
39. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912-20.
40. Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, Wu J, Du H, Chen T, Li R et al: Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open 2020, 3(3).
41. Galea S, Merchant RM, Lurie N: The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med 2020;180(6):817-8.
42. Golberstein E, Wen H, Miller BF: Coronavirus disease 2019 (COVID-19) and mental health for children and adolescents. JAMA Pediatr 2020.
43. Holmes EA, O'Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I et al: Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 2020;7(6):547-60.
44. Tan BYQ, Chew NWS, Lee GKH, Jing M, Goh Y, Yeo LLL, Zhang K, Chin H-K, Ahmad A, Khan FA et al: Psychological impact of the COVID-19 pandemic on health Care Workers in Singapore. Ann Intern Med 2020;M20-1083.
45. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D et al: Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):683-90.
46. Wujtewicz M, Dylczyk-Sommer A, Aszkielowicz A, Zdanowski S, Piwowarczyk S, Owczuk R. COVID-19 - what should anaethesiologists and intensivists know about it? Anaesthesiol Intens Ther. 2020;52(1):34-41.
47. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7.
48. Rosenbaum L: The untold toll - the Pandemic's effects on patients without Covid-19. N Engl J Med 2020;382:2368-71.
49. Chotirmall SH, Martinez FJ, Schumacker PT, Cooke CR, Seam N, Brochard L, Tighe RM, Levy BD, Gern D, Wedzicha JA: Life at the editorial 'COVID frontline': the ATS journal family. Am J Respir Crit Care Med 2020;201(12):1457-9.
50. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE et al: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;105949.
51. Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery. 2020;6(1).
52. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C et al: In vitro antiviral activity and projection of optimized dosing Design of Hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;ciaa237.
53. Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, Graef ER, Korsten P, Sattui SE, Sirotich E et al: A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of Hydroxychloroquine for COVID-19. Ann Intern Med 2020;M20-1223.
54. Yazdany J, Kim AHJ: Use of Hydroxychloroquine and Chloroquine during the COVID-19 pandemic: what every clinician should know. Ann Intern Med 2020;172(11):754-5.
55. Taccone FS, Gorham J, Vincent J-L: Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Lancet Respir Med 2020;8(6):539-41.
56. White NJ. Cardiotoxicity of antimalarial drugs. Lancet Infect Dis. 2007;7(8):549-58.
57. Liu M, Caputi TL, Dredze M, Kesselheim AS, Ayers JW: Internet searches for unproven COVID-19 therapies in the United States. JAMA Intern Med 2020;e201764.
58. Wolkewitz M, Puljak L. Methodological challenges of analysing COVID-19 data during the pandemic. BMC Med Res Methodol. 2020;20(1):81.
59. Brat GA, Weber GM, Gehlenborg N, Avillach P, Palmer NP, Chiovato L, Cimino J, Waitman LR, Omenn GS, Malovini A et al: International Electronic Health Record-Derived COVID-19 Clinical Course Profile: The 4CE Consortium. medRxiv 2020;2020.04.13.20059691.
60. Cowling BJ, Leung GM. Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Euro Surveill. 2020;25(6).